Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy

Transplant Proc. 1997 Dec;29(8):3669-70. doi: 10.1016/s0041-1345(97)01067-1.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Azathioprine / therapeutic use
  • Black People*
  • Black or African American
  • Cadaver
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Living Donors
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Philadelphia
  • Retrospective Studies
  • Tacrolimus / therapeutic use*
  • Tissue Donors
  • White People

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Mycophenolic Acid
  • Azathioprine
  • Tacrolimus